Interferon-γ and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients

European Cytokine Network

Volumn 11, Issue 4, 2000, Pages 677-681

  Franciotta, D ^a   Zardini, E ^a   Bergamaschi, R ^a   Andreoni, L ^a   Cosi, V ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Flow cytometry; IFN ; IL 4; Multiple sclerosis; Tc1 Tc2 cells; Th1 Th2 cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; FEMALE; HUMAN; IMMUNOREGULATION; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; T LYMPHOCYTE;

ADOLESCENT; ADULT; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 0034517626     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Immunologic mechanisms and therapy in multiple sclerosis
2. Exacerbations of multiple sclerosis in patients treated with gamma interferon
3. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
4. +T cell subsets in autoimmunity
5. Late complications of immune deviation therapy in a non human primate
6. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
7. + T cells secreting Th1 or Th2 cytokines
8. The expanding universe of T cell subsets: Th1, Th2 and more
9. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
10. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
11. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies
12. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the surface by two mechanisms
13. Identification of autoantibodies associated with myelin damage in multiple sclerosis
14. The adhesion molecule and cytokine profile of multiple sclerosis lesions
15. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)
16. Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4
17. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease
18. Elevated Th1-like cytokine mRNA in the peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with a monoclonal antibody to ICAM-1 correlates with clinical benefit
19. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type-1-associated myelopathy
20. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone
21. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage
22. Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease
23. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy
24. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease acticity
25. Tumor necrosis factor-α and its receptors in relapsing-remitting multiple sclerosis
26. Interferon responses of leukocytes in multiple sclerosis
27. Interferon-γ secretion by peripheral blood T cell subsets in multiple sclerosis: Correlation with disease phase and interferon-β therapy
28. Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis